These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 200160)

  • 1. Type III hyperlipoproteinemia: diagnosis in whole plasma by apolipoprotein-E immunoassay.
    Kushwaha RS; Hazzard WR; Wahl PW; Hoover JJ
    Ann Intern Med; 1977 Nov; 87(5):509-16. PubMed ID: 200160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.
    Utermann G; Vogelberg KH; Steinmetz A; Schoenborn W; Pruin N; Jaeschke M; Hees M; Canzler H
    Clin Genet; 1979 Jan; 15(1):37-62. PubMed ID: 215360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.
    Ghiselli G; Schaefer EJ; Gascon P; Breser HB
    Science; 1981 Dec; 214(4526):1239-41. PubMed ID: 6795720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III hyperlipoproteinemia: paradoxical hypolipidemic response to estrogen.
    Kushwaha RS; Hazzard WR; Gagne C; Chait A; Albers JJ
    Ann Intern Med; 1977 Nov; 87(5):517-25. PubMed ID: 200161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an automated immunoassay procedure for apo-LDL for phenotyping type II hyperlipoproteinemia.
    Nazir DJ; Brown PL; McQueen MJ
    Clin Chim Acta; 1978 Aug; 88(1):31-6. PubMed ID: 209916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric familial type III hyperlipoproteinemia.
    Glueck CJ; Fallat RW; Mellies MJ; Steiner PM
    Metabolism; 1976 Nov; 25(11):1269-74. PubMed ID: 185489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia.
    Falko JM; Schonfeld G; Witztum JL; Kolar J; Weidman SW
    Metabolism; 1979 Nov; 28(11):1171-7. PubMed ID: 226834
    [No Abstract]   [Full Text] [Related]  

  • 12. Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels?
    Ganesan D; Bass HB; McConathy WJ; Alaupovic P
    Metabolism; 1976 Nov; 25(11):1189-95. PubMed ID: 185483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
    Sandholzer C; Feussner G; Brunzell J; Utermann G
    J Clin Invest; 1992 Nov; 90(5):1958-65. PubMed ID: 1430218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormalities of apolipoprotein E (type III hyperlipoproteinemia)].
    Yamamura T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):46-9. PubMed ID: 9645005
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
    Kashyap ML; Srivastava LS; Chen CY; Perisutti CG; Campbell M; Lutmer RF; Glueck CJ
    J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population.
    Jones GJ; Hewitt D; Godin GJ; Breckenridge WC; Bird J; Mishkel MA; Steiner G; Little JA
    Can Med Assoc J; 1980 Jan; 122(1):37-8, 40-6. PubMed ID: 7363194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of thyroid-stimulating hormone in hyperlipoproteinemia.
    Vessby B; Wide L
    Clin Chim Acta; 1975 Jul; 62(2):293-7. PubMed ID: 168013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arteriosclerosis. III. Laboratory diagnosis of dyslipoproteinemia].
    Nowicka G; Kłosiewicz-Latoszek L
    Wiad Lek; 1985 Aug; 38(16):1179-84. PubMed ID: 4082589
    [No Abstract]   [Full Text] [Related]  

  • 20. Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties.
    Packard CJ; Shepherd J; Joerns S; Gotto AM; Taunton OD
    Biochim Biophys Acta; 1979 Feb; 572(2):269-82. PubMed ID: 218633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.